Navigation Links
Nanofibers from Biopolymers at the BIO International Convention in Chicago
Date:4/23/2013

Chicago, Illinois (PRWEB) April 23, 2013

In Chicago this week, Contipro Biotech, a European company, is presenting its nanotechnology device, 4SPIN, capable of preparing nano-materials from biopolymers. Thanks to this device, company expects a significant increase in new applications of biomaterials in biotech and medicine.

Why nanofibers?
Nanofibers are thousands of times finer than a human hair. Their small magnitude is ideal for many amazing applications where conventional materials are unable to achieve a comparable result. These include filtration, where the tiny pores of nanofibers can prevent the passage of viruses and bacteria, and utilization of huge surface areas of nanofibers, made possible by their slight volume. A great future is also projected in electronics, energy, optics, defence and environmental applications.

Why from biopolymers?
However, as the price of producing nano-materials remains higher than that of conventional materials, the most widespread application is expected where the benefits of nano-materials significantly outweigh their higher price. In this respect, it is also claimed that approximately two thirds of new nano-applications will be in pharmacy and medicine. This is why nanofibers from biocompatible polymers are so interesting.

Nanofibers from biopolymers can be used, for example, to create scaffolding as support for cells in the production of new tissues. Well-designed scaffolding provides support for cells and gives them signals about how to organize and develop, and how to create a graft to replace the patient’s damaged tissue. Then, on completion of the healing process, all support components are fully absorbed. An important aspect which plays a major role in determining the future development of new applications for medicine will be the ability to create the necessary structures and materials from the human body’s own substances.

About the device:
4SPIN is a high-tech electrospinning device that relies on electronic rather than manual control. Apart from the emphasis on the ability of fibrous and difficult-to-process materials, it is characterized by a high degree of operating safety. It is universally applicable, including preparation for placement in clean rooms, thus also facilitating research into medical nano-applications. A laboratory device will soon complement the pilot-operational and operational version of the apparatus.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10656376.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Join Cato BioVentures at BIO International Convention
2. Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader
3. Trigemina to Present at the 2013 BIO International Convention
4. Infinata’s BioPharm Insight to Offer Exclusive Preview of 2013 Key Reports at the BIO International Conference and Partnerships in Clinical Trials
5. Campbell Alliance to Release New Forward-Looking Industry Report on Deal-Making Trends at the 2013 BIO International Convention
6. 20 Swiss Biotech Firms and Organizations will Populate the Swiss Pavilion at BIO 2013 International Convention
7. Blood-Based Circulating Microvesicles (cMV) Data to be Presented at the 2013 International Society for Extracellular Vesicles (ISEV)
8. Dyadic International To Speak At Advanced Biofuels Leadership Conference Panel Discussion
9. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
10. Nerium International Receives the 2012 Global 100 Bravo Award for Growth
11. 31st International Symposium on Lattice Field Theory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... BEACH, Florida , February 16, 2017 /PRNewswire/ ... improving with the infusion of innovative telemedicine application, ... monitoring services that are experiencing a boom worldwide. ... with the advancement of technologies, services and new ... Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. ...
(Date:2/16/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, today announced it has ... entered into a $5 million credit facility with ... the capital for general corporate purposes to further ... treatment of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced ... professor and Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at ... practicing female physician suffering from degenerative disc disease with radiculomyelopathy, as a result ...
(Date:2/16/2017)... 16, 2017  Rhythm, a biopharmaceutical company ... that result in life-threatening metabolic disorders, today ... mezzanine round of financing with existing investors ... New Enterprise Associates, Pfizer Venture Investments, Third ... investment fund. Rhythm will use the proceeds ...
Breaking Biology Technology:
(Date:1/18/2017)... Jan. 18, 2017 MedNet Solutions ... supports the entire spectrum of clinical research, is ... record-breaking year for the organization in terms of ... MedNet,s eClinical products and services. The company,s exceptional ... success of iMedNet ™ ...
(Date:1/12/2017)... 2017  Trovagene, Inc. (NASDAQ: TROV ), ... announced that it has signed agreements with seven strategic ... Middle East for commercialization of ... first wave of international distribution agreements for Trovagene,s CLIA ... The initial partners will introduce Trovagene,s liquid ...
(Date:1/12/2017)... PUNE, India , January 12, 2017 A new ... - 2022," projects that the global biometric technology market is expected to generate revenue ... 2022. Continue Reading ... ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology News(10 mins):